Challenge 5: 3D tumour Mapping

3D tumour mapping

Tumours aren’t just composed of cancer cells – they contain a complete life support system, called the tumour microenvironment, without which the cancer cells wouldn’t survive. If we could pull the plug on the tumour’s life support, it would kill it - but first, we need to identify the crucial components.

So our Grand Challenge is to:

MAP THE MOLECULAR AND CELLULAR TUMOUR MICROENVIRONMENT IN ORDER TO DEFINE NEW TARGETS FOR THERAPY AND PROGNOSIS

Funded teams for this challenge:

Read our science blog all about this challenge

SUMMARY

Cancer cells live in complex communities. Just like houses in a city, each cell in a tumour is different from its neighbour, and relies on infrastructure to support its existence.

There are different neighbourhoods–some worse than others. Where we have roads, tumours contain blood vessels that deliver nutrients, and act as highways for different cell types to move around. And when a tumour spreads, the cancer cells themselves use these blood ‘roads’ to migrate.

What we really need is a Google Earth-like view of a tumour. If we could make a 3D map, we’d find new targets for treatment and, eventually, could use this view to track what’s going on in real time, such as in response to treatment.

BACKGROUND

A tumour is a complex and organized tissue whose behaviour reflects the interaction between heterogeneous tumour cells, immune cells,  tumour cell clones arising from stem/progenitor cells,  and the many other components of the ‘tumour microenvironment’.

There is every reason to believe that hidden within these interactions is new information and indicators about tumour behaviour, prognosis, and treatment response, as well as new therapeutic targets.

Technologies such as in situ and single-cell sequencing and high-resolution imaging can now reveal the 3D cellular and molecular details of the tumour as a real organ, whether in primary tumours or metastases.

What’s missing is a detailed map at a single cell level of the mutational and structural heterogeneity in DNA, patterns of conventional and nonconventional RNA transcription and protein expression, and the biochemical signature of all the cells and cell types in a tumour, which simultaneously captures the complexity of the intra-tumour architecture.

If achieved, this could transform the way we define and classify tumours, and would provide the basis for a dynamic view of the tumour over time and in response to treatment.

OPPORTUNITIES/BARRIERS

Although we know that different populations of cells are present within a tumour, the most common method of analysis, in which the tumour is pulled apart and cells are studied separately, gives us little or no information about why cells are there, how they got there, and what they are doing.

This Grand Challenge seeks to overcome this barrier by taking a holistic view of tumours as an integrated, organised population of cells, rather than a reductionist approach studying very small parts of the problem.

Challenge 5: Find a way of mapping tumours at the molecular and cellular level

Stay up to date

STAY UP TO DATE

Keep updated with Grand Challenge by signing up to our newsletter

You can change your mind at any time by clicking unsubscribe on one of our emails, or contacting grandchallenge@cancer.org.uk. See our Privacy Policy to learn more about how we may use your personal data

Your details are safe with us. Check out our Privacy Policy for more details.

Contact Us

lucy shaw

 

 

 

 

 

If you have a question about Grand Challenge please contact Lucy Shaw by calling 0203 469 8038 or emailing grandchallenge@cancer.org.uk

For help with our online grants system eGMS, please contact grants helpline on 0203 469 5452                   grants.helpline@cancer.org.uk

Support us

We receive no Government funding for our research, so Grand Challenge is only possible thanks to people like you.

If you've been inspired to support our most ambitious funding scheme to date, you can donate today.

Text GRANDC to 70200 to donate £10

 

 

 

Share this page